Emerging Company Profile
Led by ElevateBio’s Finer, LifeEDIT is pursuing novel enzymes for gene editing
Emerging Company Profile: AgBiome spinout LifeEDIT gains funding, gene and cell therapy expertise from ElevateBio
AgBiome spinout LifeEDIT Therapeutics gains funding, gene and cell therapy expertise and manufacturing resources from ElevateBio.
Nov 18, 2020 | 2:12 AM GMT
LifeEDIT debuted with